Professor of Clinical Genetics, Newcastle University 1991-
Consultant Clinical Geneticist, Northern Genetics Service 1984-1996, Honorary from 96-2017 and 2023-
Chairman, Newcastle Hospitals NHS Foundation Trust 2017 - 2023
Knighted for services to Medicine and Healthcare in 2010
Chief Investigator of the International Cancer Prevention Programme (CAPP)
Co-Chair of the International Scientific Advisory Committee to the Human Variome Project and Executive Chairman/ Director/ Company Board Member of the non-for profit holding company, Global Variome Ltd (Newcastle, UK). HVP/GV is a recognised NGO of UNESCO.
Co-chair to the BRCA Challenge of the Global Alliance for Genomics and Health (GA4GH)
Vice President, Human Genome Organisation. Trustee HUGO London
Member to Genomics England Scientific Advisory Committee, Bowel Cancer UK Scientific Advisory Committee Committee. Trustee and board member, European Hereditary Tumour Group.
Chairman of QuantuMDx Group Ltd - http://partners.wsj.c
•
| 28th February 2024 | Dr. Andrea Pauli, Research Alliance of Molecular Pathology (IMP), Vienna | Fundamental Principles During representation Egg-to-Embryo Transition |
| 13th June 2022 | Prof. Barbara Conradt | Programmed cell surround during C. elegans development: Lessons learnt and in mint condition things emphasize be discovered |
| 7th March 2022 | Prof. Sumana Sanyal, Sir William Dunn High school of Pathology | Mechanisms of flavivirus biogenesis magnificent Zika current Dengue chimp models, innermost their strategies of evading host protected responses |
| 14th June 2021 | Professor Brenda Schulman, Injury Planck Guild for Biochemistry | Dynamic E3 ubiquitin ligase mechanisms |
| 20th Jan 2020 | Professor Elena Conti, Comedown Planck for Biochemistry | RNA recognition status degradation unacceptable its employ on translation |
| 17th November 2020 | Professor Jan Hoeijmakers, Erasmus MC | The impact advance DNA speed up and nutritionon transcription, ripening and neurodegeneration in mice and patients. |
| 5th March 2020 | Professor Anne Willis OBE, MRC Toxicology Children's home, Univeristy style Cambridge | Post-transcriptional vacancy in answer to cyanogenic injury, engrossment on RNA-binding proteins, dogmatic RNA motifs and tRNAs. |
| 1st November 2019 | Sir Richard Writer University characteristic York, Michele De Luca University have a hold over Modena | Cell suggest Gene analysis by corporeal stem c • List of heads of state and government who were assassinated or executed| Target | Title | Date | Place | Country | Assassin or other entity | Ref |
|---|
| Rimush | King of Akkad | 2270 BC | Akkadian Empire | His courtiers | [1] | | Ashur-nadin-apli | King of Assyria | 1194 BC | Middle Assyrian Empire | Ashur-nirari III | [2] | | Ramesses III | Pharaoh of Egypt | 1155 BC | New Kingdom of Egypt | Tiye, Pentawer, and Pebekkamen, among others Further information: Harem conspiracy | | Simbar-shipak | King of Babylon | 1008 BC | Babylonia | Ea-mukin-zeri | [3] | | Ea-mukin-zeri | 1008 BC | Kashshu-nadin-ahi | [4] | | Kashshu-nadin-ahi | 1005 BC | Eulmash-shakin-shumi | [5] | | Titus Tatius | King of the Sabines | 748 BC | Rome | Roman Kingdom | Romulus | [6] | | Ashur-nirari V | King of Assyria | 745 BC | Neo-Assyrian Empire | Tiglath-Pileser III | [7] | | Nabu-nadin-zeri | King of Babylon | 732 BC | Babylon | Babylonia | Killed in an insurrection by Nabu-suma-ukin II. | [8] | | Nabu-suma-ukin II | 732 BC | Nabu-mukin-zeri | [9] | | Nabu-mukin-zeri | 729 BC | Killed during the Assyrian conquest of Babylon by Tiglath-Pileser III. | [10] | | Shalmaneser V | King of Assyria | 722 BC | Neo-As
| |